These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17457930)

  • 21. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
    Lietz K; Miller LW
    J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.
    Kremers WK; van IJperen M; Kim WR; Freeman RB; Harper AM; Kamath PS; Wiesner RH
    Hepatology; 2004 Mar; 39(3):764-9. PubMed ID: 14999695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
    Durand F; Belghiti J; Troisi R; Boillot O; Gadano A; Francoz C; de Hemptinne B; Mallet A; Valla D; Golmard JL
    Liver Transpl; 2006 Feb; 12(2):231-9. PubMed ID: 16447208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant techniques for liver transplantation in pediatric programs.
    Burgos L; Hernández F; Barrena S; Andres AM; Encinas JL; Leal N; Gamez M; Murcia J; Jara P; Lopez-Santamaria M; Tovar JA
    Eur J Pediatr Surg; 2008 Dec; 18(6):372-4. PubMed ID: 19039737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy.
    Freeman RB; Edwards EB
    Liver Transpl; 2000 Sep; 6(5):543-52. PubMed ID: 10980052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The OPTN waiting list, 1988-2003.
    Davies DB; Harper A
    Clin Transpl; 2004; ():27-40. PubMed ID: 16704136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival benefit of kidney and liver transplantation for obese patients on the waiting list.
    Pelletier SJ; Maraschio MA; Schaubel DE; Dykstra DM; Punch JD; Wolfe RA; Port FK; Merion RM
    Clin Transpl; 2003; ():77-88. PubMed ID: 15387099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatric liver transplantation in New Zealand: the first 5 years.
    Wilde J; Chin S; Johnston P; McCall J; Munn S; Nixon C; Wesley A; Young Y; Evans HM
    N Z Med J; 2007 Aug; 120(1260):U2679. PubMed ID: 17726493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The OPTN waiting list, 1988-2001.
    Harper AM; Taranto SE; Edwards EB
    Clin Transpl; 2002; ():79-92. PubMed ID: 12971437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New national liver transplant allocation policy: is the regional review board process fair?
    Voigt MD; Zimmerman B; Katz DA; Rayhill SC
    Liver Transpl; 2004 May; 10(5):666-74. PubMed ID: 15108259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation.
    Foxton MR; Kendrick S; Sizer E; Muiesan P; Rela M; Wendon J; Heaton ND; O'Grady JG; Heneghan MA
    Transpl Int; 2006 Dec; 19(12):988-94. PubMed ID: 17081228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
    Rhee EK; Canter CE; Basile S; Webber SA; Naftel DC
    J Heart Lung Transplant; 2007 May; 26(5):447-52. PubMed ID: 17449412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of thoracic organ transplantation and allocation in the United States.
    Coke M; Edwards LB
    Clin Transpl; 2004; ():17-26. PubMed ID: 16704135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation.
    Keith D; Ashby VB; Port FK; Leichtman AB
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):463-70. PubMed ID: 18199847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.